REJUVITAS
Rejuvitas is working on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming. The company was founded in 2021 and is headquartered in New York.
REJUVITAS
Industry:
Biotechnology Health Care Neuroscience
Founded:
2021-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.rejuvitas.com
Total Employee:
1+
Status:
Active
Contact:
332-334-6130
Total Funding:
3.3 M USD
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Founder
Official Site Inspections
http://www.rejuvitas.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rejuvitas"
Rejuvitas - Crunchbase Company Profile & Funding
Rejuvitas is working on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming. The company was founded in 2021 and is …See details»
Rejuvitas Company Profile 2024: Valuation, Funding & Investors
Developer of novel gene therapies designed to employ metabolic reprogramming and regenerative medicine technologies.See details»
Rejuvitas - Funding, Financials, Valuation & Investors - Crunchbase
Rejuvitas works on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming.See details»
Rejuvitas – Funding, Valuation, Investors, News
Rejuvitas is developing genetic and metabolic regenerative medicine therapies that address the underlying common cause of retinal degeneration and several significant neurodegenerative …See details»
Rejuvitas, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Rejuvitas, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Rejuvitas - Company Profile - Tracxn
Oct 19, 2024 · Rejuvitas - Developer of gene therapies for neuro degenerative disorders. Raised a total funding of $8.3M over 2 rounds. Founded by Andrea Spezzi in the year 2021.See details»
Rejuvitas - VentureRadar
Rejuvitas provides novel gene therapies employing metabolic reprogramming and regenerative medicine technologies developed in the lab of acclaimed geneticist, Stephen Tsang, M.D., …See details»
Membership Directory - Corporate | NewYorkBIO
Rejuvitas is developing genetic and metabolic regenerative medicine therapies that address the underlying common cause of retinal degeneration and several significant neurodegenerative …See details»
Rejuvitas – Funding, Valuation, Investors, News | Parsers VC
Sep 9, 2022 · Rejuvitas is developing genetic and metabolic regenerative medicine therapies that address the underlying common cause of retinal degeneration and several significant …See details»
Rejuvitas - Crunchbase
Rejuvitas works on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming.See details»
Medical Excellence Capital Announces $145 Million …
Aug 23, 2022 · Rejuvitas is a gene therapy company, cofounded by MEC, that provides novel gene therapies employing metabolic reprogramming and regenerative medicine technologies developed in the lab of...See details»
Rejuvitas - Products, Competitors, Financials, Employees, …
Rejuvitas is a provider of gene therapies intended to employ metabolic reprogramming and regenerative medicine technologies. The company was founded in 2021 and is based in New …See details»
Rejuvitas - Raised $8.3M Funding from investors - Tracxn
Nov 4, 2024 · Rejuvitas has raised a total funding of $8.3M over 2 rounds. Their latest funding round was of $5M on Sep 07, 2022 .See details»
Rejuvitas Inc. - BioCentury Company Profiles - BCIQ
Aug 23, 2022 · Rejuvitas Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Rejuvitas, Inc. - fund raising filing
Sep 7, 2022 · Rejuvitas, Inc. - Most recent fund raising on September 7, 2022 raised $4,999,996 in Equity.See details»
Rejuvitas - Updates, News, Events, Signals & Triggers - Crunchbase
Rejuvitas works on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming.See details»
John Prufeta Profile: Contact Information & Network - PitchBook
Information on current and former positions, network members and contacts for John Prufeta. Use the PitchBook Platform to explore the full profile.See details»
Seed Round - Rejuvitas - 2022-01-25 - Crunchbase
Dec 29, 2021 · Rejuvitas raised $3300000 on 2022-01-25 in Seed RoundSee details»
VCCT Inc. - VentureRadar
Rejuvitas is developing genetic and metabolic regenerative medicine therapies that address the underlying common cause of retinal degeneration and several significant neurodegenerative …See details»
Venture Round - Rejuvitas - 2022-09-07 - Crunchbase
Rejuvitas raised $4999996 on 2022-09-07 in Venture Round. Start Free Trial . Chrome ExtensionSee details»